News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
211,866 Results
Type
Article (12831)
Company Profile (23)
Press Release (199009)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (48274)
Career Advice (366)
Deals (9643)
Drug Delivery (33)
Drug Development (40517)
Employer Resources (13)
FDA (7508)
Job Trends (4352)
News (106667)
Policy (11175)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (897)
Accelerated approval (12)
Adcomms (12)
Allergies (75)
Alliances (12198)
ALS (89)
Alzheimer's disease (696)
Antibody-drug conjugate (ADC) (87)
Approvals (7714)
Artificial intelligence (133)
Autoimmune disease (61)
Automation (19)
Bankruptcy (70)
Best Places to Work (4068)
BIOSECURE Act (4)
Biosimilars (76)
Biotechnology (22)
Bladder cancer (66)
Brain cancer (20)
Breast cancer (223)
Cancer (1832)
Cardiovascular disease (196)
Career advice (318)
Career pathing (9)
CAR-T (105)
CDC (22)
Cell therapy (279)
Cervical cancer (14)
Clinical research (37141)
Collaboration (462)
Compensation (119)
Complete response letters (33)
COVID-19 (1312)
CRISPR (17)
C-suite (193)
Cystic fibrosis (56)
Data (3463)
Denatured (1)
Depression (71)
Diabetes (323)
Diagnostics (1670)
Digital health (20)
Diversity, equity & inclusion (3)
Drug discovery (86)
Drug pricing (46)
Drug shortages (10)
Duchenne muscular dystrophy (95)
Earnings (24249)
Editorial (14)
Employer resources (12)
Events (25282)
Executive appointments (195)
FDA (9078)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (9)
Funding (407)
Gene editing (37)
Generative AI (12)
Gene therapy (199)
GLP-1 (473)
Government (1741)
Grass and pollen (5)
Guidances (227)
Healthcare (5529)
HIV (22)
Huntington's disease (26)
IgA nephropathy (51)
Immunology and inflammation (85)
Immuno-oncology (17)
Indications (62)
Infectious disease (1468)
Inflammatory bowel disease (102)
Inflation Reduction Act (5)
Influenza (71)
Intellectual property (95)
Interviews (67)
IPO (4705)
IRA (17)
Job creations (494)
Job search strategy (260)
JPM (10)
Kidney cancer (7)
Labor market (14)
Layoffs (70)
Leadership (13)
Legal (1532)
Liver cancer (50)
Longevity (6)
Lung cancer (284)
Lymphoma (144)
Machine learning (15)
Management (8)
Manufacturing (265)
MASH (96)
Medical device (4946)
Medtech (4966)
Mergers & acquisitions (5305)
Metabolic disorders (677)
Multiple sclerosis (103)
NASH (7)
Neurodegenerative disease (123)
Neuropsychiatric disorders (34)
Neuroscience (1352)
NextGen: Class of 2026 (1662)
Non-profit (996)
Now hiring (14)
Obesity (245)
Opinion (93)
Ovarian cancer (67)
Pain (111)
Pancreatic cancer (100)
Parkinson's disease (145)
Partnered (13)
Patents (202)
Patient recruitment (270)
Peanut (36)
People (12272)
Pharmaceutical (8)
Pharmacy benefit managers (10)
Phase 1 (8983)
Phase 2 (16537)
Phase 3 (13993)
Pipeline (2574)
Policy (81)
Postmarket research (1294)
Preclinical (3278)
Press Release (12)
Prostate cancer (84)
Psychedelics (9)
Radiopharmaceuticals (38)
Rare diseases (320)
Real estate (1112)
Recruiting (4)
Regulatory (9949)
Reports (16)
Research institute (789)
Resumes & cover letters (39)
Rett syndrome (18)
RNA editing (3)
RSV (52)
Schizophrenia (88)
Series A (63)
Series B (46)
Sickle cell disease (28)
Special edition (4)
Spinal muscular atrophy (93)
Sponsored (20)
Startups (662)
State (1)
Stomach cancer (6)
Supply chain (31)
Tariffs (13)
The Weekly (3)
Vaccines (515)
Venture capital (14)
Weight loss (153)
Women's health (44)
Worklife (5)
Date
Last 7 days (200)
Last 30 days (743)
Last 365 days (11580)
2026 (1022)
2025 (11687)
2024 (13042)
2023 (14793)
2022 (17853)
2021 (19442)
2020 (18477)
2019 (13869)
2018 (10635)
2017 (10824)
2016 (9748)
2015 (11125)
2014 (8127)
2013 (5975)
2012 (6402)
2011 (6975)
2010 (6154)
Location
Africa (217)
Alabama (39)
Alaska (1)
Arizona (58)
Arkansas (4)
Asia (14053)
Australia (2299)
California (4083)
Canada (1301)
China (507)
Colorado (174)
Connecticut (204)
Delaware (160)
Europe (30163)
Florida (632)
Georgia (179)
Hawaii (1)
Idaho (15)
Illinois (255)
India (31)
Indiana (165)
Iowa (4)
Japan (226)
Kansas (54)
Kentucky (13)
Louisiana (12)
Maine (22)
Maryland (437)
Massachusetts (2778)
Michigan (100)
Minnesota (194)
Mississippi (1)
Missouri (51)
Montana (8)
Nebraska (11)
Nevada (49)
New Hampshire (22)
New Jersey (1302)
New Mexico (5)
New York (1300)
North Carolina (514)
North Dakota (5)
Northern California (2069)
Ohio (76)
Oklahoma (5)
Oregon (15)
Pennsylvania (792)
Puerto Rico (12)
Rhode Island (11)
South America (294)
South Carolina (13)
Southern California (1523)
Tennessee (44)
Texas (601)
United States (14501)
Utah (88)
Virginia (80)
Washington D.C. (27)
Washington State (324)
West Virginia (1)
Wisconsin (13)
211,866 Results for "physio control".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Laborie Acquires the JADA® System for Rapid Postpartum Hemorrhage Control, Expanding Obstetrics Portfolio
January 29, 2026
·
4 min read
Press Releases
Machina Medical Receives FDA 510(k) Clearance for MFUSE External Bleeding Control Device
January 20, 2026
·
1 min read
Press Releases
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company
February 4, 2026
·
1 min read
Press Releases
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
February 2, 2026
·
7 min read
Press Releases
NEW DATA DEMONSTRATE QLOSI™ IS PUPIL SELECTIVE WITH CILIARY MUSCLE MOVEMENT NO DIFFERENT THAN A BALANCED SALT SOLUTION (BSS) CONTROL
January 28, 2026
·
7 min read
Press Releases
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
February 1, 2026
·
5 min read
Deals
Inogen Completes Acquisition of Physio-Assist
Inogen, Inc. announced it has completed the acquisition of Physio-Assist SAS, expanding the company’s innovative respiratory portfolio.
September 18, 2023
·
4 min read
Press Releases
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
January 19, 2026
·
3 min read
Press Releases
Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
January 20, 2026
·
15 min read
1 of 21,187
Next
